IMA Q4 2022 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-73.0% YoY

Gross Profit

-$10M-187.0% margin

Operating Income

-$15M-277.3% margin

Net Income

-$14M-258.7% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-14.9%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$172M

Total Liabilities

$25M

Stockholders' Equity

$147M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$20M	-73.0%
Gross Profit	-$10M	$8M	-229.3%
Operating Income	-$15M	$3M	-641.3%
Net Income	-$14M	$3M	-604.0%